Adulteration of Drugs and Foods: Compendial Approaches to Lowering Risk

The instances of adulteration of excipients in drug products with diethylene glycol (DEG), and of pet food with melamine, are well‐publicized examples of public health risks. This article describes a risk‐reduction strategy that is at the core of US food and drug law—testing to public documentary st...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2009-04, Vol.85 (4), p.444-447
Main Authors: Abernethy, DR, Sheehan, C, Griffiths, JC, Williams, RL
Format: Article
Language:English
Subjects:
Animals
Biological and medical sciences
Drug Contamination - legislation & jurisprudence
Drug Contamination - prevention & control
Drug-Related Side Effects and Adverse Reactions
Food - adverse effects
Food - standards
Food Contamination - analysis
Food Contamination - legislation & jurisprudence
Food Contamination - prevention & control
Humans
Medical sciences
Pharmaceutical Preparations - analysis
Pharmaceutical Preparations - standards
Pharmacology. Drug treatments
Risk Factors
United States
United States Food and Drug Administration - legislation & jurisprudence
United States Food and Drug Administration - standards
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The instances of adulteration of excipients in drug products with diethylene glycol (DEG), and of pet food with melamine, are well‐publicized examples of public health risks. This article describes a risk‐reduction strategy that is at the core of US food and drug law—testing to public documentary standards and using allied reference materials when needed. Clinical Pharmacology & Therapeutics (2009); 85, 4, 444–447 doi:10.1038/clpt.2008.88
ISSN:0009-9236
1532-6535
DOI:10.1038/clpt.2008.88